Logo

VELOCITY CLINICAL RESEARCH 401(K) PLAN 401k Plan overview

Plan NameVELOCITY CLINICAL RESEARCH 401(K) PLAN
Plan identification number 001

VELOCITY CLINICAL RESEARCH 401(K) PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

VELOCITY CLINICAL RESEARCH, INC has sponsored the creation of one or more 401k plans.

Company Name:VELOCITY CLINICAL RESEARCH, INC
Employer identification number (EIN):823171064
NAIC Classification:541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan VELOCITY CLINICAL RESEARCH 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012024-01-01KIMBERLY BALLARD
0012023-01-01
0012023-01-01KIMBERLY BALLARD
0012022-01-01
0012022-01-01
0012022-01-01
0012022-01-01KIMBERLY BALLARD
0012021-01-01
0012021-01-01NHU HAO TRAN
0012020-01-01JEFFREY ROE2021-07-20

Financial Data on VELOCITY CLINICAL RESEARCH 401(K) PLAN

Measure Date Value
2023 : VELOCITY CLINICAL RESEARCH 401(K) PLAN 2023 401k financial data
Total unrealized appreciation/depreciation of assets2023-12-31$0
Total transfer of assets to this plan2023-12-31$7,806,562
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-12-31$0
Total income from all sources (including contributions)2023-12-31$12,300,451
Total loss/gain on sale of assets2023-12-31$0
Total of all expenses incurred2023-12-31$2,860,354
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-12-31$2,745,706
Value of total corrective distributions2023-12-31$8,055
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-12-31$9,584,634
Value of total assets at end of year2023-12-31$26,827,746
Value of total assets at beginning of year2023-12-31$9,581,087
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-12-31$106,593
Total interest from all sources2023-12-31$14,661
Total dividends received (eg from common stock, registered investment company shares)2023-12-31$535,758
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2023-12-31$535,758
Was this plan covered by a fidelity bond2023-12-31Yes
Value of fidelity bond cover2023-12-31$1,000,000
If this is an individual account plan, was there a blackout period2023-12-31No
Were there any nonexempt tranactions with any party-in-interest2023-12-31No
Contributions received from participants2023-12-31$5,471,577
Participant contributions at end of year2023-12-31$374,450
Participant contributions at beginning of year2023-12-31$109,487
Participant contributions at end of year2023-12-31$15,651
Participant contributions at beginning of year2023-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2023-12-31$1,355,371
Total non interest bearing cash at end of year2023-12-31$0
Total non interest bearing cash at beginning of year2023-12-31$452
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Value of net income/loss2023-12-31$9,440,097
Value of net assets at end of year (total assets less liabilities)2023-12-31$26,827,746
Value of net assets at beginning of year (total assets less liabilities)2023-12-31$9,581,087
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2023-12-31No
Were any leases to which the plan was party in default or uncollectible2023-12-31No
Investment advisory and management fees2023-12-31$41,572
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-12-31$26,432,469
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-12-31$9,471,148
Interest on participant loans2023-12-31$14,661
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-12-31$2,165,398
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-12-31No
Was there a failure to transmit to the plan any participant contributions2023-12-31Yes
Has the plan failed to provide any benefit when due under the plan2023-12-31No
Contributions received in cash from employer2023-12-31$2,757,686
Employer contributions (assets) at end of year2023-12-31$5,176
Employer contributions (assets) at beginning of year2023-12-31$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-12-31$2,745,706
Contract administrator fees2023-12-31$65,021
Did the plan have assets held for investment2023-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-12-31No
Opinion of an independent qualified public accountant for this plan2023-12-31Unqualified
Accountancy firm name2023-12-31FORVIS MAZARS, LLP
Accountancy firm EIN2023-12-31441060260
Total unrealized appreciation/depreciation of assets2023-01-01$0
Total transfer of assets to this plan2023-01-01$7,806,562
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-01-01$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2023-01-01$0
Total income from all sources (including contributions)2023-01-01$12,300,451
Total loss/gain on sale of assets2023-01-01$0
Total of all expenses incurred2023-01-01$2,860,354
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2023-01-01$2,745,706
Value of total corrective distributions2023-01-01$8,055
Total contributions o plan (from employers,participants, others, non cash contrinutions)2023-01-01$9,584,634
Value of total assets at end of year2023-01-01$26,827,746
Value of total assets at beginning of year2023-01-01$9,581,087
Total of administrative expenses incurred including professional, contract, advisory and management fees2023-01-01$106,593
Total interest from all sources2023-01-01$14,661
Total dividends received (eg from common stock, registered investment company shares)2023-01-01$535,758
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2023-01-01No
Total dividends received from registered investment company shares (eg mutual funds)2023-01-01$535,758
Was this plan covered by a fidelity bond2023-01-01Yes
Value of fidelity bond cover2023-01-01$1,000,000
If this is an individual account plan, was there a blackout period2023-01-01No
Were there any nonexempt tranactions with any party-in-interest2023-01-01No
Contributions received from participants2023-01-01$5,471,577
Participant contributions at end of year2023-01-01$374,450
Participant contributions at beginning of year2023-01-01$109,487
Participant contributions at end of year2023-01-01$15,651
Participant contributions at beginning of year2023-01-01$0
Income. Received or receivable in cash from other sources (including rollovers)2023-01-01$1,355,371
Total non interest bearing cash at end of year2023-01-01$0
Total non interest bearing cash at beginning of year2023-01-01$452
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2023-01-01No
Value of net income/loss2023-01-01$9,440,097
Value of net assets at end of year (total assets less liabilities)2023-01-01$26,827,746
Value of net assets at beginning of year (total assets less liabilities)2023-01-01$9,581,087
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2023-01-01No
Were any loans by the plan or fixed income obligations due to the plan in default2023-01-01No
Were any leases to which the plan was party in default or uncollectible2023-01-01No
Investment advisory and management fees2023-01-01$41,572
Value of interest in registered invesment companies (eg mutual funds) at end of year2023-01-01$26,432,469
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2023-01-01$9,471,148
Interest on participant loans2023-01-01$14,661
Net investment gain/loss from registered investment companies (e.g. mutual funds)2023-01-01$2,165,398
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2023-01-01No
Was there a failure to transmit to the plan any participant contributions2023-01-01Yes
Has the plan failed to provide any benefit when due under the plan2023-01-01No
Contributions received in cash from employer2023-01-01$2,757,686
Employer contributions (assets) at end of year2023-01-01$5,176
Employer contributions (assets) at beginning of year2023-01-01$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2023-01-01$2,745,706
Contract administrator fees2023-01-01$65,021
Did the plan have assets held for investment2023-01-01Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2023-01-01No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2023-01-01No
Opinion of an independent qualified public accountant for this plan2023-01-011
Accountancy firm name2023-01-01FORVIS MAZARS, LLP
Accountancy firm EIN2023-01-01441060260
2022 : VELOCITY CLINICAL RESEARCH 401(K) PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total transfer of assets to this plan2022-12-31$1,084,788
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$2,428,036
Total loss/gain on sale of assets2022-12-31$0
Total of all expenses incurred2022-12-31$868,516
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$826,667
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$3,754,431
Value of total assets at end of year2022-12-31$9,581,087
Value of total assets at beginning of year2022-12-31$6,936,779
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$41,849
Total interest from all sources2022-12-31$2,893
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$185,585
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$185,585
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$1,000,000
If this is an individual account plan, was there a blackout period2022-12-31Yes
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$2,139,933
Participant contributions at end of year2022-12-31$109,487
Participant contributions at beginning of year2022-12-31$92,081
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$538,428
Total non interest bearing cash at end of year2022-12-31$452
Total non interest bearing cash at beginning of year2022-12-31$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$1,559,520
Value of net assets at end of year (total assets less liabilities)2022-12-31$9,581,087
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$6,936,779
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Investment advisory and management fees2022-12-31$16,940
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$9,471,148
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$6,760,777
Interest on participant loans2022-12-31$2,893
Value of interest in common/collective trusts at end of year2022-12-31$0
Value of interest in common/collective trusts at beginning of year2022-12-31$83,921
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-1,514,873
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$1,076,070
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$826,667
Contract administrator fees2022-12-31$24,909
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32022-12-31Yes
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31FORVIS, LLP
Accountancy firm EIN2022-12-31441060260
Total unrealized appreciation/depreciation of assets2022-01-01$0
Total transfer of assets to this plan2022-01-01$1,071,378
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-01-01$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-01-01$0
Total income from all sources (including contributions)2022-01-01$2,433,954
Total loss/gain on sale of assets2022-01-01$0
Total of all expenses incurred2022-01-01$868,516
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-01-01$826,667
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-01-01$3,754,431
Value of total assets at end of year2022-01-01$9,581,087
Value of total assets at beginning of year2022-01-01$6,944,271
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-01-01$41,849
Total interest from all sources2022-01-01$2,893
Total dividends received (eg from common stock, registered investment company shares)2022-01-01$185,585
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-01-01No
Total dividends received from registered investment company shares (eg mutual funds)2022-01-01$185,585
Was this plan covered by a fidelity bond2022-01-01Yes
Value of fidelity bond cover2022-01-01$1,000,000
If this is an individual account plan, was there a blackout period2022-01-01Yes
Were there any nonexempt tranactions with any party-in-interest2022-01-01No
Contributions received from participants2022-01-01$2,139,933
Participant contributions at end of year2022-01-01$109,487
Participant contributions at beginning of year2022-01-01$99,572
Income. Received or receivable in cash from other sources (including rollovers)2022-01-01$538,428
Total non interest bearing cash at end of year2022-01-01$452
Total non interest bearing cash at beginning of year2022-01-01$6,844,699
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-01-01No
Value of net income/loss2022-01-01$1,565,438
Value of net assets at end of year (total assets less liabilities)2022-01-01$9,581,087
Value of net assets at beginning of year (total assets less liabilities)2022-01-01$6,944,271
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-01-01No
Were any loans by the plan or fixed income obligations due to the plan in default2022-01-01No
Were any leases to which the plan was party in default or uncollectible2022-01-01No
Investment advisory and management fees2022-01-01$16,940
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-01-01$9,471,148
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-01-01$0
Interest on participant loans2022-01-01$2,893
Value of interest in common/collective trusts at end of year2022-01-01$0
Value of interest in common/collective trusts at beginning of year2022-01-01$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-01-01$-1,508,955
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-01-01No
Was there a failure to transmit to the plan any participant contributions2022-01-01Yes
Has the plan failed to provide any benefit when due under the plan2022-01-01No
Contributions received in cash from employer2022-01-01$1,076,070
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-01-01$826,667
Contract administrator fees2022-01-01$24,909
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32022-01-01Yes
Did the plan have assets held for investment2022-01-01Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-01-01No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-01-01No
Opinion of an independent qualified public accountant for this plan2022-01-011
Accountancy firm name2022-01-01FORVIS, LLP
Accountancy firm EIN2022-01-01441060260
2021 : VELOCITY CLINICAL RESEARCH 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total transfer of assets to this plan2021-12-31$4,036,316
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$3,096,904
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$915,297
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$866,600
Expenses. Certain deemed distributions of participant loans2021-12-31$0
Value of total corrective distributions2021-12-31$12,921
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$2,452,262
Value of total assets at end of year2021-12-31$6,944,271
Value of total assets at beginning of year2021-12-31$726,348
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$35,776
Total interest from all sources2021-12-31$4,228
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$205,902
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$205,902
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$1,000,000
If this is an individual account plan, was there a blackout period2021-12-31No
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$1,092,360
Participant contributions at end of year2021-12-31$99,572
Participant contributions at beginning of year2021-12-31$15,637
Assets. Other investments not covered elsewhere at end of year2021-12-31$0
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$1,147,821
Other income not declared elsewhere2021-12-31$26,467
Administrative expenses (other) incurred2021-12-31$35,776
Total non interest bearing cash at end of year2021-12-31$6,844,699
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$2,181,607
Value of net assets at end of year (total assets less liabilities)2021-12-31$6,944,271
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$726,348
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$670,580
Interest on participant loans2021-12-31$4,228
Value of interest in common/collective trusts at end of year2021-12-31$0
Value of interest in common/collective trusts at beginning of year2021-12-31$40,131
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2021-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$406,977
Net investment gain or loss from common/collective trusts2021-12-31$1,068
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$212,081
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$866,600
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Opinion of an independent qualified public accountant for this plan2021-12-31Disclaimer
Accountancy firm name2021-12-31FORVIS, LLP
Accountancy firm EIN2021-12-31440160260

Form 5500 Responses for VELOCITY CLINICAL RESEARCH 401(K) PLAN

2023: VELOCITY CLINICAL RESEARCH 401(K) PLAN 2023 form 5500 responses
2023-01-01Type of plan entitySingle employer plan
2023-01-01Submission has been amendedNo
2023-01-01This submission is the final filingNo
2023-01-01This return/report is a short plan year return/report (less than 12 months)No
2023-01-01Plan is a collectively bargained planNo
2023-01-01Plan funding arrangement – TrustYes
2023-01-01Plan benefit arrangement - TrustYes
2022: VELOCITY CLINICAL RESEARCH 401(K) PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement - TrustYes
2021: VELOCITY CLINICAL RESEARCH 401(K) PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement - TrustYes

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S1